OXTELLAR XR 300 mg/1 (Oxcarbazepine TABLET) 300 mg/1

Oxcarbazepine is an anticonvulsant medication used to manage seizures and nerve pain. Oxstellar XR 300 mg/1 is an extended-release tablet designed for consistent dosing.

Strength

300 mg/1

Pack Size

5 TABLET in 1 BLISTER PACK (17772-122-10)

Manufacturer / TM Owner

Supernus Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxcarbazepine is primarily used to control partial seizures in epilepsy. It may also be prescribed for nerve pain conditions. The extended-release formulation of Oxstellar XR 300 mg/1 helps maintain steady levels of the medication in the body, which can be beneficial for long-term management.

Side Effects

Common effects of oxcarbazepine may include dizziness, drowsiness, and nausea. Some users report headaches or fatigue. These effects vary and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

Oxcarbazepine should be handled with care, especially for those with a history of kidney or liver issues. It is important to follow the prescribed dosage and consult a healthcare provider before making any changes. Always store the medication in a cool, dry place.

Avoid Interactions

Oxcarbazepine may interact with other medications, including certain antidepressants and birth control pills. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided as it may increase the risk of side effects.

Frequently Asked Questions

Oxcarbazepine is primarily used to manage partial seizures in epilepsy and may also be prescribed for nerve pain conditions.

The extended-release formulation of Oxstellar XR 300 mg/1 is designed to release the medication slowly over time, helping to maintain steady levels in the body.

Common side effects may include dizziness, drowsiness, nausea, headaches, and fatigue. These effects vary and may diminish over time.

Oxcarbazepine may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Oxcarbazepine should be stored in a cool, dry place, away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.